Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,869,216
+$498,556 QoQ
Shares Held
15,376
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#1,477
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. ABBV ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,869,216 | 15,376 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,370,660 | 15,498 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,555,532 | 15,561 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,625,684 | 15,659 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,915,347 | 15,706 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,289,883 | 15,702 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,798,419 | 15,748 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,129,070 | 15,845 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,755,811 | 16,067 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,925,254 | 16,064 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,535,309 | 16,360 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,484,383 | 16,667 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,258,478 | 16,763 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,671,041 | 16,760 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,760,460 | 17,081 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,332,301 | 17,378 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,680,300 | 17,500 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,836,438 | 17,497 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,477,007 | 18,294 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,919,007 | 17,790 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,003,415 | 17,786 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,924,476 | 17,783 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,919,913 | 17,918 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,565,671 | 17,875 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,754,574 | 17,871 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,363,420 | 17,895 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||